NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Cliffs Natural (CLF) was downgraded at Goldman to sell. $25 price target. Company is facing higher costs and could miss production targets, Goldman said.Coach (COH) was initiated with an outperform rating at Wells Fargo. Company can continue to grow across the globe and in women's accessories, Wells Fargo said. Cryolife (CRY) downgraded to hold at TheStreet.com. Emerson (EMR) was downgraded at Oppenheimer to perform from outperform. $53 price target. Lack of high conviction catalysts, Oppenheimer said.
Ford (F) downgraded to hold at TheStreet.com. Greif (GEF) was downgraded at Wells Fargo from outperform to market perform. Company is leveraged to a weaker macro environment, Wells Fargo said. Intel (INTC - Get Report) was downgraded at UBS to neutral from buy. $21.50 price target. CEO transition raises uncertainty, UBS said. Joy Global (JOYG) was upgraded at BMO Capital from underperform to market perform. $64 price target. Valuation call, as the stock is down 45% from its highs, BMO said. Merck (MRK - Get Report) was upgraded at MKM Partners from neutral to buy. $51 price target. Company has a robust clinical pipeline, MKM said. Palo Alto (PANW) was initiated with a neutral rating at Nomura. Valuation call, based on a $60 price target, Nomura said.
Pentair (PNR) was upgraded at Robert Baird from neutral to outperform. $60 price target. Management should be able to achieve long-term earnings targets, Baird said. Research In Motion (RIMM) was upgraded at Jefferies to hold from underperform. $10 price target. Strong BB10 carrier support, Jefferies said. Realogy (RLGY) was initiated with a neutral rating at Goldman. $34 price target. See limited upside to near-term EBITDA estimates, Goldman said. Realogy was initiated with a buy rating at BofA/Merrill. $41 price target. Company can realize higher operating leverage, BofA/Merrill said.
SVB Financial Group (SIVB) upgraded at Citigroup to Buy from Neutral, Citigroup said. $63 price target. Has sold off in sympathy with other regionals. Tyson Foods (TSN) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $25 price target. Estimates also boosted, as the company is realizing higher margins. UnitedHealth (UNH) rated new Buy at Lazard, $70 price target. Company is a market leader focused on managing care. Whole Foods (WFM) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $106 price target. Company can expand margins as it continues to attract new shoppers.
STOCK COMMENTS / EPS CHANGESAgilent Technologies (A) numbers cut at Citigroup. Shares of A now seen reaching $43, Citigroup said. Estimates also lowered on weaker than expected guidance. Buy rating. Agilent Technologies numbers lowered at Jefferies. Shares of A now seen reaching $51, Jefferies said. Estimates also lowered on possible departure from operating model. Buy rating. Lowe's (LOW) estimates, target boosted at Nomura. Shares of LOW now seen reaching $40, according to Nomura. Estimates also upped, as the company is seeing better sales and margins. Buy rating. Lowe's numbers raised at UBS. Shares of LOW now seen reaching $39, UBS said. Estimates also raised as 3Q was a step in the right direction. NCR (NCR) added to Focus List at JP Morgan. Estimates also boosted, as the company is expanding its product offerings. News Corp. (NWSA) numbers raised at Credit Suisse. Shares of NWSA now seen reaching $28, according to Credit Suisse. Estimates also increased, as the Consolidated Media purchase should add to earnings. Neutral rating. Urban Outfitters (URBN) numbers raised at Nomura. Shares of URBN now seen reaching $35, according to Nomura. Company is making good progress at Anthropologie. Neutral rating. Urban Outfitters numbers raised at Jefferies. Shares of URBN now seen reaching $25, Jefferies said. Estimates also raised on domestic growth. Underperform rating. >To submit a news tip, email: email@example.com.
Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts